The detailed information for PTAB case with proceeding number IPR2019-00695 filed by Nalox-1 Pharmaceuticals, LLC et al. against Opiant Pharmaceuticals, Inc. on Feb 19, 2019. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number
IPR2019-00695
Filing Date
Feb 19, 2019
Petitioner
Nalox-1 Pharmaceuticals, LLC et al.
Respondent
Opiant Pharmaceuticals, Inc.
Status
Institution Denied
Respondent Application Number
15335145
Respondent Tech Center
1600
Respondent Patent Number
9629965
Institution Decision Date
Oct 1, 2019

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.


Document NameFiling DateCategoryFiling Party

Alert me when new update on this case

JOINT NOTICE OF STIPULATION REGARDING SCHEDULING

Mar 6, 2020PAPERPETITIONER

Notice of Refund

Oct 21, 2019PAPERBOARD

PETITIONER NALOX-1 PHARMACEUTICALS, LLC¿¿¿S REQUEST FOR REFUND OF POST-INSTITUTION FEES

Oct 3, 2019PAPERPETITIONER

Trial Instituted Document

Oct 1, 2019PAPERBOARD

PATENT OWNER'S RESPONSE TO PETITIONER'S NOTICE

Aug 12, 2019PAPERPATENT OWNER

Petitioner's Notice

Aug 5, 2019PAPERPETITIONER

Conduct of the Proceeding 37 C.F.R. sec 42.5

Jul 31, 2019PAPERBOARD

Opiant2001 Williams Decl

Jul 1, 2019EXHIBITPATENT OWNER

Opiant2002 Amphastar Press Release

Jul 1, 2019EXHIBITPATENT OWNER

Opiant2003 Aquina 2009

Jul 1, 2019EXHIBITPATENT OWNER

Opiant2004 Baca 2005

Jul 1, 2019EXHIBITPATENT OWNER

Opiant2007 Burford Press Release

Jul 1, 2019EXHIBITPATENT OWNER

Opiant2009 FDA Teva Press Release

Jul 1, 2019EXHIBITPATENT OWNER

Opiant2010 Gaddis 1992

Jul 1, 2019EXHIBITPATENT OWNER

Opiant2011 Goldfranks

Jul 1, 2019EXHIBITPATENT OWNER

Opiant2014 Letter from Ten Congressmen

Jul 1, 2019EXHIBITPATENT OWNER

Opiant2005 Belz 2006

Jul 1, 2019EXHIBITPATENT OWNER

Opiant2006 Buajordet 2004

Jul 1, 2019EXHIBITPATENT OWNER

Opiant2008 EVZIO Prescribing Information

Jul 1, 2019EXHIBITPATENT OWNER

Opiant2012 Indivior Press Release

Jul 1, 2019EXHIBITPATENT OWNER

Opiant2013 Kelly 2002

Jul 1, 2019EXHIBITPATENT OWNER

Opiant2017 Osterwalder 1996

Jul 1, 2019EXHIBITPATENT OWNER

Opiant2018 Pallasch 1981

Jul 1, 2019EXHIBITPATENT OWNER

Opiant2019 Popper 1989

Jul 1, 2019EXHIBITPATENT OWNER

Opiant2021 Sporer 1996

Jul 1, 2019EXHIBITPATENT OWNER

Opiant2022 Sporer 2007

Jul 1, 2019EXHIBITPATENT OWNER

Opiant2023 Stoove 2009

Jul 1, 2019EXHIBITPATENT OWNER

Opiant2024 Terman 2012 Slides

Jul 1, 2019EXHIBITPATENT OWNER

Opiant2027 van Dorp 2007

Jul 1, 2019EXHIBITPATENT OWNER

Opiant2028 Walley 2013

Jul 1, 2019EXHIBITPATENT OWNER

Opiant2029 Wermeling 2015

Jul 1, 2019EXHIBITPATENT OWNER

Opiant2030 Wermeling 354

Jul 1, 2019EXHIBITPATENT OWNER

Opiant2034 US9211253

Jul 1, 2019EXHIBITPATENT OWNER

Opiant2035 US9468747

Jul 1, 2019EXHIBITPATENT OWNER

Opiant2015 Loimer 1992

Jul 1, 2019EXHIBITPATENT OWNER

Opiant2016 Narcan Nasal Spray Prescribing Information

Jul 1, 2019EXHIBITPATENT OWNER

Opiant2020 Schwartz 1987

Jul 1, 2019EXHIBITPATENT OWNER

Opiant2025 Teva Case Claim Construction Opinion

Jul 1, 2019EXHIBITPATENT OWNER

Opiant2026 Teva Case Schedule Stipulation

Jul 1, 2019EXHIBITPATENT OWNER

Opiant2031 Williams 2019

Jul 1, 2019EXHIBITPATENT OWNER

Opiant2032 Yealy 1990

Jul 1, 2019EXHIBITPATENT OWNER

Opiant2033 Zuckerman 2014

Jul 1, 2019EXHIBITPATENT OWNER

Opiant2036 US9561177

Jul 1, 2019EXHIBITPATENT OWNER

Opiant2037 Minute Entry

Jul 1, 2019EXHIBITPATENT OWNER

PRELIMINARY RESPONSE OF PATENT OWNER OPIANT PHARMACEUTICALS, INC.

Jul 1, 2019PAPERPATENT OWNER

Notice of Accord Filing Date

Apr 1, 2019PAPERBOARD

MANDATORY NOTICES OF PATENT OWNER OPIANT PHARMACEUTICALS, INC.

Mar 12, 2019PAPERPATENT OWNER

POWER OF ATTORNEY FOR OPIANT PHARMACEUTICALS, INC.

Mar 12, 2019PAPERPATENT OWNER

Power of Attorney

Feb 19, 2019PAPERPETITIONER

Nalox1001 U. S. Patent 9,629,965

Feb 19, 2019EXHIBITPETITIONER

Nalox1003 Hochhaus Declaration - 695

Feb 19, 2019EXHIBITPETITIONER

Petition

Feb 19, 2019PAPERPETITIONER

Nalox1002 Donovan Declaration - 695

Feb 19, 2019EXHIBITPETITIONER

Nalox1007 U.S. Patent No. 9,192,570 (Wyse)

Feb 19, 2019EXHIBITPETITIONER

Nalox1008 Chinese Patent No. 1,575,795 (Wang)

Feb 19, 2019EXHIBITPETITIONER

Nalox1010 Djupesland (2013)

Feb 19, 2019EXHIBITPETITIONER

Nalox1012 Handbook of Pharmaceutical Excipients

Feb 19, 2019EXHIBITPETITIONER

Nalox1013 Kushwaha (2011)

Feb 19, 2019EXHIBITPETITIONER

Nalox1015 U.S. Patent No. 8,198,291

Feb 19, 2019EXHIBITPETITIONER

Nalox1017 Alabama EMS Protocols (2013)

Feb 19, 2019EXHIBITPETITIONER

Nalox1018 APTAR Press Release

Feb 19, 2019EXHIBITPETITIONER

Nalox1023 Boyer (2012)

Feb 19, 2019EXHIBITPETITIONER

Nalox1024 CDC - Zomig Review

Feb 19, 2019EXHIBITPETITIONER

Nalox1025 Commonwealth Kentucky Patient Care Protocols (2015)

Feb 19, 2019EXHIBITPETITIONER

Nalox1026 Costantino (2007)

Feb 19, 2019EXHIBITPETITIONER

Nalox1027 Dowling (2008)

Feb 19, 2019EXHIBITPETITIONER

Nalox1030 Freise (2012)

Feb 19, 2019EXHIBITPETITIONER

Nalox1004 FH 15/183,441 Excerpt - Aug. 22, 2016 Action

Feb 19, 2019EXHIBITPETITIONER

Nalox1005 FH 15/183,441 Excerpt - Oct. 21, 2016 Resp.

Feb 19, 2019EXHIBITPETITIONER

Nalox1009 WO 00/62,757 (Davies)

Feb 19, 2019EXHIBITPETITIONER

Nalox1011 Grassin-Delyle (2012)

Feb 19, 2019EXHIBITPETITIONER

Nalox1014 U.S. Patent No. 5,866,154 (Bahal)

Feb 19, 2019EXHIBITPETITIONER

Nalox1016 Wermeling (2013)

Feb 19, 2019EXHIBITPETITIONER

Nalox1019 Ashton (2006)

Feb 19, 2019EXHIBITPETITIONER

Nalox1020 Barton (2002)

Feb 19, 2019EXHIBITPETITIONER

Nalox1021 Barton (2005)

Feb 19, 2019EXHIBITPETITIONER

Nalox1022 Bitter (2011)

Feb 19, 2019EXHIBITPETITIONER

Nalox1028 2002 FDA Guidance

Feb 19, 2019EXHIBITPETITIONER

Nalox1029 2003 FDA Guidance

Feb 19, 2019EXHIBITPETITIONER

Nalox1032 Hertz Presentation

Feb 19, 2019EXHIBITPETITIONER

Nalox1037 Kleiman-Wexler (1989)

Feb 19, 2019EXHIBITPETITIONER

Nalox1038 Marple (2004)

Feb 19, 2019EXHIBITPETITIONER

Nalox1039 Merck Index

Feb 19, 2019EXHIBITPETITIONER

Nalox1040 Merlin (2010)

Feb 19, 2019EXHIBITPETITIONER

Nalox1042 Monitto (2011)

Feb 19, 2019EXHIBITPETITIONER

Nalox1044 PDR (2003)

Feb 19, 2019EXHIBITPETITIONER

Nalox1031 Glende (2016)

Feb 19, 2019EXHIBITPETITIONER

Nalox1034 Kelly (2005)

Feb 19, 2019EXHIBITPETITIONER

Nalox1035 Kerr (2008)

Feb 19, 2019EXHIBITPETITIONER

Nalox1036 Kerr (2009)

Feb 19, 2019EXHIBITPETITIONER

Nalox1041 Middleton (2011)

Feb 19, 2019EXHIBITPETITIONER

Nalox1043 Lemke (2008)

Feb 19, 2019EXHIBITPETITIONER

Nalox1047 Robertson (2009)

Feb 19, 2019EXHIBITPETITIONER

Nalox1048 Role of Naloxone (76 Fed Reg. 71,348)

Feb 19, 2019EXHIBITPETITIONER

Nalox1049 Role of Naloxone (Full Transcript)

Feb 19, 2019EXHIBITPETITIONER

Nalox1054 USP 36-NF 31

Feb 19, 2019EXHIBITPETITIONER

Nalox1058 U.S. Provisional Patent App. 61/953379

Feb 19, 2019EXHIBITPETITIONER

Nalox1059 Wermeling (2010)

Feb 19, 2019EXHIBITPETITIONER

Nalox1060 Loimer (1994)

Feb 19, 2019EXHIBITPETITIONER

Nalox1061 Doe-Simkins (2009)

Feb 19, 2019EXHIBITPETITIONER

Nalox1062 McDermott (2012)

Feb 19, 2019EXHIBITPETITIONER

Nalox1065 Wisconsin Affidavit_Part 1 of 2

Feb 19, 2019EXHIBITPETITIONER

Nalox1006 FH 15/183,441 Excerpt - Dec. 21, 2016 NOA

Feb 19, 2019EXHIBITPETITIONER

Nalox1045 PDR (2010)

Feb 19, 2019EXHIBITPETITIONER

Nalox1046 Robertson (2005)

Feb 19, 2019EXHIBITPETITIONER

Nalox1050 Rosanske (1986)

Feb 19, 2019EXHIBITPETITIONER

Nalox1051 Sabzghabaee (2014)

Feb 19, 2019EXHIBITPETITIONER

Nalox1053 Trows (2014)

Feb 19, 2019EXHIBITPETITIONER

Nalox1055 U.S. Patent Appl. No. 61/918,802

Feb 19, 2019EXHIBITPETITIONER

Nalox1056 U.S. Patent No. 5,307,953

Feb 19, 2019EXHIBITPETITIONER

Nalox1057 U.S. Patent No. 5,813,570

Feb 19, 2019EXHIBITPETITIONER

Nalox1063 Notice of Allowance from USP 9,629,965 FH

Feb 19, 2019EXHIBITPETITIONER

Nalox1064 Butler Affidavit

Feb 19, 2019EXHIBITPETITIONER

Nalox1065 Wisconsin Affidavit_Part 2 of 2

Feb 19, 2019EXHIBITPETITIONER

Nalox1066 Lipscomb Affidavit

Feb 19, 2019EXHIBITPETITIONER